Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E-52862 for post-surgical neuropathic pain
2012-000402-30Phase 2Completed
- Sponsor
- Esteve
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Neuralgia comparing E-52862 400 mg with Placebo (2 arms). Primary endpoint: Analgesic efficacy of E-52862. Started Apr 2012; status: completed.
02
Drugs
E-52862
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2012-000402-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000402-30.